Related by context. Frequent words. (Click for all words.) 56 www.crucell.com 56 teleconferencing numbers 54 regular syndicated columnists 53 Twitter http:/twitter.com/StockPreacher 52 Complete corrected 52 Corrected copy 50 Twitter http:/twitter.com/BeaconEquity 49 Paris IPN 49 Twitter @ mastercardnews 48 Twitter @ IndustryToday 47 http:/individuals.eatonvance.com 47 FermaVir 46 Inc. Nasdaq TRMS 46 Epimmune 46 TLR9 agonists 45 NASDAQ CRXL 45 @ videodrew 45 Seeking Alpha publishes 45 Enrolls First 45 WILEX 44 Twitter Doc 0 44 Corautus 44 M Enoxaparin 44 Combination Agreement 44 Syntonix 43 Warrantholders 43 UVIDEM 43 Subsequent Offering 43 Nasdaq VRTX 43 Phase IIa clinical trials 43 Prestara 43 Focetria 43 shares issuable pursuant 43 Offer Prospectus 42 5TH CIR 42 Nasdaq CRXL 42 Nasdaq MNKD 42 GVAX R 42 Visit www.otc advisors.com 42 Crucell NV Euronext 42 e.preventDefault e.preventDefault 42 commercialize telaprevir 42 Proxy Statement dated 42 Loss Coverage Ratios 42 NVA# 41 exhibits thereto 41 Investigational Device Exemption 41 anidulafungin 41 Product Characteristics 41 Deckers Outdoor NASDAQ DECK 41 BLA submission 41 Milestone Payment 41 Dynepo 41 Share Repurchase Plan 41 Combination Transaction 41 Marketing Authorisation 41 Pierre Fabre Medicament 41 BioInvent 40 Galapagos NV 40 supplemental biologics 40 Entry Period 40 Affitech 40 obj obj = 40 CEFF 40 Preferred Stockholders 40 Hepatitis C HCV 40 stockholder approvals 40 Securities Purchase Agreement 40 faropenem 40 daptomycin 40 Engulfing Bullish Candle Illustration 40 Movetis 40 eprodisate KIACTA TM 40 Proposed Financing 40 Article Continues 39 Engulfing Bearish Candle Illustration 39 By Avi Krawitz 39 Market Characteristics chapter 39 Commercialization Agreement 39 NV Organon 39 Rotarix R 39 Application MAA 39 Ramoplanin 39 Icatibant 39 Amended Agreement 39 Shigamabs R 39 applicable Total Consideration 39 Amalgamation Agreement 39 Mandatory Convertible Preferred Stock 39 Second Tranche 38 Merger Transaction 38 NetFlix NASDAQ NFLX 38 anti CD# monoclonal 38 Arigene 38 Biotie 38 CDP# 38 Jerini AG 38 disinterested shareholder 38 BioGlue R 38 TapImmune 38 Act PDUFA date